INNOVATION
Anti-inflammatory product order boost for MGC
PERTH: Trailblazing bio-pharma company MGC Pharmaceuticals, who specialises in the development and production of phytocannabinoid-derived… read more
Singular builds reconstructive surgery 3D capability
PERTH: Singular Health has moved to strengthen its suite of medical imaging products by entering… read more
FDA approves self-injectable formulation of Xolair
SEATTLE: The FDA has approved a self-injectable formulation of Xolair for appropriate patients with moderate… read more
Dedalus says ICS future requires open health eco-system
FLORENCE: On 1 April Dedalus completed its £350million acquisition of DXC Healthcare from DXC Technology,… read more
